Application 205489
- Type
- NDA
- Sponsor
- NEOS THERAPS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | COTEMPLA XR-ODT | METHYLPHENIDATE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | 8.6MG | Yes | No |
| 002 | COTEMPLA XR-ODT | METHYLPHENIDATE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | 17.3MG | Yes | No |
| 003 | COTEMPLA XR-ODT | METHYLPHENIDATE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | 25.9MG | Yes | No |
| 004 | COTEMPLA XR-ODT | METHYLPHENIDATE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | 34.6MG | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N205489-001 | COTEMPLA XR-ODT | METHYLPHENIDATE | 8.6MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | AB | RLD | 2017-06-19 |
| N205489-002 | COTEMPLA XR-ODT | METHYLPHENIDATE | 17.3MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | AB | RLD | 2017-06-19 |
| N205489-003 | COTEMPLA XR-ODT | METHYLPHENIDATE | 25.9MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2017-06-19 |
| N205489-004 | COTEMPLA XR-ODT | METHYLPHENIDATE | 34.6MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD | 2024-08-19 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N205489-001 | AB |
| N205489-002 | AB |
| N205489-003 | AB |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N205489-001 | 8840924 | 2026-06-05 | Drug product | 2017-07-20 | |
| N205489-001 | 9072680 | 2032-06-28 | Drug product | 2017-07-20 | |
| N205489-001 | 9089496 | 2032-06-28 | Drug product | 2017-07-20 | |
| N205489-001 | 11166947 | 2038-01-25 | U-3299 | 2022-02-10 | |
| N205489-002 | 8840924 | 2026-06-05 | Drug product | 2017-07-20 | |
| N205489-002 | 9072680 | 2032-06-28 | Drug product | 2017-07-20 | |
| N205489-002 | 9089496 | 2032-06-28 | Drug product | 2017-07-20 | |
| N205489-002 | 11166947 | 2038-01-25 | U-3299 | 2022-02-10 | |
| N205489-003 | 8840924 | 2026-06-05 | Drug product | 2017-07-20 | |
| N205489-003 | 9072680 | 2032-06-28 | Drug product | 2017-07-20 | |
| N205489-003 | 9089496 | 2032-06-28 | Drug product | 2017-07-20 | |
| N205489-003 | 11166947 | 2038-01-25 | U-3299 | 2022-02-10 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N205489-001 | COTEMPLA XR-ODT | 8.6MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD | 2017-06-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N205489-002 | COTEMPLA XR-ODT | 17.3MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD | 2017-06-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N205489-003 | COTEMPLA XR-ODT | 25.9MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD, RS | 2017-06-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N205489-004 | COTEMPLA XR-ODT | 34.6MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD | 2024-08-19 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205489-001 | COTEMPLA XR-ODT | 8.6MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD | 2017-06-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205489-002 | COTEMPLA XR-ODT | 17.3MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD | 2017-06-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205489-003 | COTEMPLA XR-ODT | 25.9MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD, RS | 2017-06-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205489-004 | COTEMPLA XR-ODT | 34.6MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD | 2024-08-19 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N205489-001 | COTEMPLA XR-ODT | 8.6MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD | 2017-06-19 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N205489-002 | COTEMPLA XR-ODT | 17.3MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD | 2017-06-19 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N205489-003 | COTEMPLA XR-ODT | 25.9MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD, RS | 2017-06-19 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N205489-004 | COTEMPLA XR-ODT | 34.6MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD | 2024-08-19 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205489-001 | COTEMPLA XR-ODT | 8.6MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD | 2017-06-19 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205489-002 | COTEMPLA XR-ODT | 17.3MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD | 2017-06-19 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205489-003 | COTEMPLA XR-ODT | 25.9MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD, RS | 2017-06-19 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205489-004 | COTEMPLA XR-ODT | 34.6MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD | 2024-08-19 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205489-001 | COTEMPLA XR-ODT | 8.6MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD | 2017-06-19 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205489-002 | COTEMPLA XR-ODT | 17.3MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD | 2017-06-19 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205489-003 | COTEMPLA XR-ODT | 25.9MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD, RS | 2017-06-19 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205489-004 | COTEMPLA XR-ODT | 34.6MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD | 2024-08-19 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205489-001 | COTEMPLA XR-ODT | 8.6MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD | 2017-06-19 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205489-002 | COTEMPLA XR-ODT | 17.3MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD | 2017-06-19 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205489-003 | COTEMPLA XR-ODT | 25.9MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD, RS | 2017-06-19 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205489-004 | COTEMPLA XR-ODT | 34.6MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD | 2024-08-19 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205489-001 | COTEMPLA XR-ODT | 8.6MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD | 2017-06-19 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205489-002 | COTEMPLA XR-ODT | 17.3MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD | 2017-06-19 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205489-003 | COTEMPLA XR-ODT | 25.9MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD, RS | 2017-06-19 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205489-004 | COTEMPLA XR-ODT | 34.6MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD | 2024-08-19 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N205489-001 | COTEMPLA XR-ODT | 8.6MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD | 2017-06-19 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N205489-002 | COTEMPLA XR-ODT | 17.3MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD | 2017-06-19 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N205489-003 | COTEMPLA XR-ODT | 25.9MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD, RS | 2017-06-19 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N205489-004 | COTEMPLA XR-ODT | 34.6MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD | 2024-08-19 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N205489-001 | COTEMPLA XR-ODT | 8.6MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD | 2017-06-19 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N205489-002 | COTEMPLA XR-ODT | 17.3MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD | 2017-06-19 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N205489-003 | COTEMPLA XR-ODT | 25.9MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD, RS | 2017-06-19 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N205489-004 | COTEMPLA XR-ODT | 34.6MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD | 2024-08-19 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N205489-001 | COTEMPLA XR-ODT | 8.6MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD | 2017-06-19 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N205489-002 | COTEMPLA XR-ODT | 17.3MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD | 2017-06-19 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N205489-003 | COTEMPLA XR-ODT | 25.9MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD, RS | 2017-06-19 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N205489-004 | COTEMPLA XR-ODT | 34.6MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE / ORAL | RLD | 2024-08-19 | d06236e962d9… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N205489-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N205489-002 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N205489-003 | AB | 1 | a50c72e98297… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N205489-001 | 8840924 | 2026-06-05 | Drug product | 2017-07-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N205489-001 | 9072680 | 2032-06-28 | Drug product | 2017-07-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N205489-001 | 9089496 | 2032-06-28 | Drug product | 2017-07-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N205489-001 | 11166947 | 2038-01-25 | U-3299 | 2022-02-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N205489-002 | 8840924 | 2026-06-05 | Drug product | 2017-07-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N205489-002 | 9072680 | 2032-06-28 | Drug product | 2017-07-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N205489-002 | 9089496 | 2032-06-28 | Drug product | 2017-07-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N205489-002 | 11166947 | 2038-01-25 | U-3299 | 2022-02-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N205489-003 | 8840924 | 2026-06-05 | Drug product | 2017-07-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N205489-003 | 9072680 | 2032-06-28 | Drug product | 2017-07-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N205489-003 | 9089496 | 2032-06-28 | Drug product | 2017-07-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N205489-003 | 11166947 | 2038-01-25 | U-3299 | 2022-02-10 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205489-001 | 8840924 | 2026-06-05 | Drug product | 2017-07-20 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205489-001 | 9072680 | 2032-06-28 | Drug product | 2017-07-20 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205489-001 | 9089496 | 2032-06-28 | Drug product | 2017-07-20 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205489-001 | 11166947 | 2038-01-25 | U-3299 | 2022-02-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205489-002 | 8840924 | 2026-06-05 | Drug product | 2017-07-20 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205489-002 | 9072680 | 2032-06-28 | Drug product | 2017-07-20 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205489-002 | 9089496 | 2032-06-28 | Drug product | 2017-07-20 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205489-002 | 11166947 | 2038-01-25 | U-3299 | 2022-02-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205489-003 | 8840924 | 2026-06-05 | Drug product | 2017-07-20 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205489-003 | 9072680 | 2032-06-28 | Drug product | 2017-07-20 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205489-003 | 9089496 | 2032-06-28 | Drug product | 2017-07-20 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205489-003 | 11166947 | 2038-01-25 | U-3299 | 2022-02-10 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N205489-001 | 8840924 | 2026-06-05 | Drug product | 2017-07-20 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N205489-001 | 9072680 | 2032-06-28 | Drug product | 2017-07-20 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N205489-001 | 9089496 | 2032-06-28 | Drug product | 2017-07-20 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N205489-001 | 11166947 | 2038-01-25 | U-3299 | 2022-02-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N205489-002 | 8840924 | 2026-06-05 | Drug product | 2017-07-20 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N205489-002 | 9072680 | 2032-06-28 | Drug product | 2017-07-20 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N205489-002 | 9089496 | 2032-06-28 | Drug product | 2017-07-20 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N205489-002 | 11166947 | 2038-01-25 | U-3299 | 2022-02-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N205489-003 | 8840924 | 2026-06-05 | Drug product | 2017-07-20 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N205489-003 | 9072680 | 2032-06-28 | Drug product | 2017-07-20 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N205489-003 | 9089496 | 2032-06-28 | Drug product | 2017-07-20 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N205489-003 | 11166947 | 2038-01-25 | U-3299 | 2022-02-10 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205489-001 | 8840924 | 2026-06-05 | Drug product | 2017-07-20 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205489-001 | 9072680 | 2032-06-28 | Drug product | 2017-07-20 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205489-001 | 9089496 | 2032-06-28 | Drug product | 2017-07-20 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205489-001 | 11166947 | 2038-01-25 | U-3299 | 2022-02-10 | fd3edfee7708… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N205489-001 | NP | 2020-06-19 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N205489-002 | NP | 2020-06-19 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N205489-003 | NP | 2020-06-19 | 74a2ff9319b5… |
| 2020-12-22 03:56 UTC | 2020-12 | N205489-001 | NP | 2020-06-19 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N205489-002 | NP | 2020-06-19 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N205489-003 | NP | 2020-06-19 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N205489-001 | NP | 2020-06-19 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N205489-002 | NP | 2020-06-19 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N205489-003 | NP | 2020-06-19 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N205489-001 | NP | 2020-06-19 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N205489-002 | NP | 2020-06-19 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N205489-003 | NP | 2020-06-19 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N205489-001 | NP | 2020-06-19 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N205489-002 | NP | 2020-06-19 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N205489-003 | NP | 2020-06-19 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N205489-001 | NP | 2020-06-19 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N205489-002 | NP | 2020-06-19 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N205489-003 | NP | 2020-06-19 | ea99ee380514… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methylphenidate Extended-Release | METHYLPHENIDATE EXTENDED-RELEASE | Neos Therapeutics, LP | c2fec19b-6610-4ce0-8e60-f8218a11f62f | 2026-06-16 | Boxed warning, Warnings, Adverse reactions | 205489 NDA205489 |
| Cotempla XR-ODT | METHYLPHENIDATE | Neos Therapeutics Brands, LLC | 33f70f58-c871-42c8-8adb-345caeafefcd | 2025-09-24 | Boxed warning, Warnings, Adverse reactions | 205489 NDA205489 70165-200 70165-100 70165-300 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 70165-100 | Cotempla XR-ODT | Methylphenidate | Neos Therapeutics, LP | NDA | Current |
| 70165-100 | Cotempla XR-ODT | Methylphenidate | Neos Therapeutics, LP | NDA | Current |
| 70165-100 | Cotempla XR-ODT | Methylphenidate | Neos Therapeutics Brands, LLC | NDA | Current |
| 70165-100 | Cotempla XR-ODT | Methylphenidate | Neos Therapeutics Brands, LLC | NDA | Current |
| 70165-100 | Cotempla XR-ODT | Methylphenidate | Neos Therapeutics Brands, LLC | NDA | Current |
| 70165-100 | Cotempla XR-ODT | Methylphenidate | Neos Therapeutics Brands, LLC | NDA | Current |
| 70165-200 | Cotempla XR-ODT | Methylphenidate | Neos Therapeutics, LP | NDA | Current |
| 70165-200 | Cotempla XR-ODT | Methylphenidate | Neos Therapeutics, LP | NDA | Current |
| 70165-200 | Cotempla XR-ODT | Methylphenidate | Neos Therapeutics Brands, LLC | NDA | Current |
| 70165-200 | Cotempla XR-ODT | Methylphenidate | Neos Therapeutics Brands, LLC | NDA | Current |
| 70165-200 | Cotempla XR-ODT | Methylphenidate | Neos Therapeutics Brands, LLC | NDA | Current |
| 70165-200 | Cotempla XR-ODT | Methylphenidate | Neos Therapeutics Brands, LLC | NDA | Current |
| 70165-300 | Cotempla XR-ODT | Methylphenidate | Neos Therapeutics, LP | NDA | Current |
| 70165-300 | Cotempla XR-ODT | Methylphenidate | Neos Therapeutics, LP | NDA | Current |
| 70165-300 | Cotempla XR-ODT | Methylphenidate | Neos Therapeutics Brands, LLC | NDA | Current |
| 70165-300 | Cotempla XR-ODT | Methylphenidate | Neos Therapeutics Brands, LLC | NDA | Current |
| 70165-300 | Cotempla XR-ODT | Methylphenidate | Neos Therapeutics Brands, LLC | NDA | Current |
| 70165-300 | Cotempla XR-ODT | Methylphenidate | Neos Therapeutics Brands, LLC | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 83489 | SUPPL | 2025-09-25 |
| 83488 | SUPPL | 2025-09-25 |
| 83449 | SUPPL | 2025-09-25 |
| 78400 | SUPPL | 2024-05-06 |
| 78396 | SUPPL | 2024-05-06 |
| 75771 | SUPPL | 2023-10-16 |
| 75731 | SUPPL | 2023-10-16 |
| 67955 | SUPPL | 2021-06-29 |
| 67954 | SUPPL | 2021-06-29 |
| 67938 | SUPPL | 2021-06-29 |
| 52883 | ORIG | 2018-03-09 |
| 48790 | ORIG | 2017-06-22 |
| 48787 | ORIG | 2017-06-20 |
| 48786 | ORIG | 2017-06-19 |
| 51372 | ORIG | 1900-01-01 |
| 51371 | ORIG | 1900-01-01 |
| 51370 | ORIG | 1900-01-01 |
| 51369 | ORIG | 1900-01-01 |
| 51367 | ORIG | 1900-01-01 |